MIRA INFORM REPORT

 

 

Report Date :

25.03.2014

 

IDENTIFICATION DETAILS

 

Name :

KUSUM HEALTHCARE PRIVATE LIMITED (w.e.f. 22.12.2004)

 

 

Formerly Known As :

K. B. FINVEST AND REALESTATES PRIVATE LIMITED

 

 

Registered Office :

D-158 A, Okhla Industrial Area, Phase- I, New Delhi – 110020

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

12.03.1997

 

 

Com. Reg. No.:

55-085780

 

 

Capital Investment / Paid-up Capital :

Rs.79.905 Millions

 

 

CIN No.:                              

[Company Identification No.]

U65929DL1997PTC085780

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELK0745C

 

 

PAN No.:

[Permanent Account No.]

AABCK7043B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals Products. 

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (53)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 6217000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a successor of proprietary concern established in 1977.

 

Then in 2001, the constitution was changed to partnership firm and later in December 2004, the firm was incorporated into “Kusum Healthcare Private Limited”.

 

It is a well established and reputed company having satisfactory track record.

 

The company possesses a favourable financial profile marked by adequate networth position.

 

Management has seen an improvement in its sales volume as well as net profitability along with healthy profit margin during 2013.

 

Trade relations are fair. Business is active. Payment terms are reported as regular.

 

In view of established track record of the promoters, the subject can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit for the fiscal third quarter ended September 2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9 billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and moderation in gold imports. Manufacturing activity and new orders in India showed their strongest growth in a year in February. The news comes as a relief after data showed Asia’s third largest economy grew by a slower-than-expected 4.7 % annually in the three months through December. The HSBC Manufacturing Purchasing Managers’ Index which gauges the business activity of India’s factories but not its’ utilities, rose to 52.5 in February, its highest in a year from 51.4 in January. Overall new orders for factory goods which rose to a one-year high of 54.9 contributed to the surge. China has emerged as India’s biggest trading partner in the current financial year replacing the United Arab Emirates and pushing it to the third spot. India-China trade has reached $49.5 billion with a 8.7 % share in India’s total trade. The US comes second at $46 billion with 8.1 % share during the first nine months of the current financial year.

 

The Reserve Bank of India has granted an additional nine months to the public to exchange currency notes printed before 2005 including Rs 500 and Rs 1,000 denominations, pushing the deadline to January 1, 2015. A day before dates for the Lok Sabha polls were announced, the government decided to hike interest rates on fixed deposit schemes offered by post offices up to 0.2 per cent. The new rates will be effective April, 1. The Supreme Court will resume hearing on March, 11 Nokia’s appeal against a ruling over transferring ownership of its local mobile phones plant which is the subject of a tax dispute to Microsoft Corp.

 

In the last days of the current Government, another scam has surfaced. The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The Central Bureau of Investigation will look into allegations that over $80 million was paid in kickbacks in a deal signed in 2011. India has asked Boeing Co. to find a solution for problems with state-owned Air India’s 787 Dreamliners. The aircraft has experienced a series of malfunctions since its debut in 2011.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

FUND BASED LIMIT : ICRA BBB

Rating Explanation

Having moderate degree of safety regarding timely servicing of financial obligation it carry moderate credit risk.

Date

September 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. S K Shetty

Designation :

Account Manager

Contact No.:

91-1493-516560

Date :

21.03.2014

 

 

LOCATIONS

 

Registered Office :

D-158 A, Okhla Industrial Area, Phase- I, New Delhi – 110020, India

Tel. No.:               

91-11-40527575/ 41005147

Fax No.:

91-11-23550714/ 40527575

E-Mail :

preeti.cs@kusumhealthcare.com

deepika.cs@kusumhealthcare.com

pharmacovigilance@kusumhealthcare.com                    

swapnil.cs@kusumhealthcare.com

Website :                             

www.kusumhealthcare.com

 

 

Corporate Office :

2E/22, Jhanddewalan Extension, New Delhi – 110055, India

Tel. No.:

91-11-23678130/31

Fax No.:

91-11-23550714

 

 

Factory  :

Plot No. SP 289 (A), RIICO Industrial Area, Chopanki, Bhiwadi, Alwar (District), Rajasthan, India

Tel. No.:

91-1493-516560/61

Fax No.:

91-1493-516562                                                                     

 

 

Branch Office:

Located at

  • Ukraine
  • Moldova
  • Kazakhstan
  • Uzbekistan

 

 

DIRECTORS

 

As on: 28.09.2013

 

Name :          

Mr. Badri Prasad Gupta

Designation :

Director

Address :

BU-102, Pitam Pura, Delhi - 110034, India

Date of Birth/Age :

17.10.1938

Date of Appointment :

29.12.2004

PAN No.:

AAWPG7278E

DIN No.:

00837192

 

 

Name :

Mr. Sanjeev Gupta

Designation :

Managing Director

Address :                

B-4/117, Safdarjung Enclave, Delhi-110029, India

Date of Birth/Age :

08.10.1967

Date of Appointment :

12.03.1997

PAN No.:

ABLPG4307Q

DIN No.:

00837248

 

 

Name :

Mr. Pramod Madhav Sapre

Designation :

Director

Address :

401, Vaishali Apartment, 15/21, Janki Kutir, Juhu, Mumbai – 400049, Maharashtra, India  

Date of Birth/Age :

08.07.1938

Date of Appointment :

11.11.2011

DIN No.:

01972457

 

 

KEY EXECUTIVES

 

Name :          

Mr. S K Shetty

Designation :

Account Manager

 

 

Name :          

Mr. Swapnil Gupta

Designation :

Secretary

Address :

H. No. 115, Mashiak Ganj, Lucknow – 226018, Uttar Pradesh, India

Date of Birth/Age :

25.10.1984

Experience :

22.04.2013

PAN No.:

BAHPG9408A

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 28.09.2012

 

Names of Shareholders

 

No. of Shares

Sanjeev Gupta

 

5718120

Kusum Rani Gupta

 

469040

Badri Prasad Gupta

 

1702340

Seema Gupta

 

1000

Nirupma Gupta

 

100000

 

 

 

Total

 

7990500

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 28.09.2012

 

Category

 

Percentage

Directors or relatives of directors

 

100.00

Total

 

100.00

                                 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Products.

 

 

Exports :

 

Products :

Pharmaceuticals Products

Countries :

Ukraine

 

 

Imports :

 

Products :

Raw Materials

Countries :

Singapore

 

 

GENERAL INFORMATION

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

 

 

  • Oriental Bank of Commerce, Delhi, India
  • Axis Bank Limited
  • Central Bank of India
  • Karnataka Bank

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

0.000

2.858

SHORT-TERM BORROWINGS

 

 

Working capital loans from banks

0.000

35.905

 

 

 

Total

0.000

38.763

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

ASPN and company

Chartered Accountants

Address :

3927/28, Padam Singh Road, Karol Bagh, New Delhi-110005, India

PAN No.:

AACFK3713C

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

  • Glad Pharma Limited
  • Kusum Pharma

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7990500

Equity Shares

Rs.10/- each

Rs.79.905 Millions

 

 

 

 

 

 

                                   


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

79.905

79.905

79.905

(b) Reserves & Surplus

1474.356

1192.093

980.014

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1554.261

1271.998

1059.919

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

2.858

6.208

(b) Deferred tax liabilities (Net)

3.401

7.329

7.734

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

6.018

4.941

3.723

Total Non-current Liabilities (3)

9.419

15.128

17.665

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.548

35.905

41.828

(b) Trade payables

112.195

75.341

35.084

(c) Other current liabilities

17.220

25.177

88.828

(d) Short-term provisions

22.079

22.149

50.736

Total Current Liabilities (4)

152.042

158.572

216.476

 

 

 

 

TOTAL

1715.722

1445.698

1294.060

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

258.994

235.581

240.331

(ii) Intangible Assets

9.901

7.476

6.797

(iii) Capital work-in-progress

0.000

10.413

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

42.198

27.609

2.595

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

311.093

281.079

249.723

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

91.950

65.521

38.264

(c) Trade receivables

1195.793

970.647

855.343

(d) Cash and cash equivalents

38.723

9.106

5.570

(e) Short-term loans and advances

78.163

118.239

136.075

(f) Other current assets

0.000

1.106

9.085

Total Current Assets

1404.629

1164.619

1044.337

 

 

 

 

TOTAL

1715.722

1445.698

1294.060

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Gross Sales

1414.209

1050.024

1199.543

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PRIOR PERIOD ITEMS

0.000

0.000

0.024

 

 

 

 

 

 

PROFIT BEFORE TAX

443.238

304.702

424.712

 

 

 

 

 

 

TAX                                                                 

144.148

108.400

13.576

 

 

 

 

 

 

PROFIT AFTER TAX

299.090

196.302

411.136

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

1192.093

980.014

568.878

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

22.660

0.000

0.000

 

 

Dividend

14.383

0.000

0.000

 

 

Tax on Dividend

2.444

0.000

0.000

 

BALANCE CARRIED TO THE B/S

1451.696

1192.093

980.014

 

 

 

 

 

 

Earnings Per Share (Rs.)

                    37.43

24.57

51.45

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Return on Total Assets

(PBT/Total Assets}

(%)

                   25.83

21.23

32.82

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.29

0.24

0.40

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.03

0.05

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

9.24

7.34

4.82

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

79.905

79.905

79.905

Reserves & Surplus

980.014

1,192.093

1,474.356

Net worth

1059.919

1271.998

1554.261

 

 

 

 

long-term borrowings

6.208

2.858

0.000

Short term borrowings

41.828

35.905

0.548

Total borrowings

48.036

38.763

0.548

Debt/Equity ratio

0.045

0.030

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Gross Sales

1199.543

1050.024

1414.209

 

 

(12.465)

34.683

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

1199.543

1050.024

1414.209

Profit

411.136

196.302

299.090

 

34.27%

18.70%

21.15%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment                

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees          

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year                     

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2013

As on

31.03.2012

SHORT-TERM BORROWINGS

 

 

Deposits from directors

0.548

         0.000

 

 

 

Total

0.548

         0.000

 

 

NOTE:

 

The registered office address of the company has been shifted from “21/4, Bhagat Singh Marg, New Delhi – 110001, Delhi, India” to the present address w.e.f. 18.05.2012.

 

 

PERFORMANCE AND OPERATIONS

 

The Company’s revenue from operations during the financial year 2012-13 amounted to Rs. 1410.000 Millions against Rs. 1050.000 Millions in the previous year recording a growth of more than 35percent. This was primarily due to improved realizations, changes in the product mix and induction of new products. As a result, profit after tax increased by more than 53 percent to 30 Millions from Rs. 200.000 Millions in the previous financial year. Another critical focus of this programme is to improve cost effectiveness across products while upholding the highest standards of regulatory, quality and safety requirements. Kusum Healthcare strives to maintain world-class quality for its products and services across all markets. The reserves of the Company have increased from Rs. 1190.000 Millions to Rs. 1470.000 Millions.

 

Company export wide variety of pharmaceutical products to Common wealth of Independent State (CIS) Countries like Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Moldova and ASEAN countries like Philippines and Vietnam and continuously explores the business opportunities with other countries.

 

 

FUTURE PROSPECTS AND OUTLOOK

 

The company focus will be to channelise the company’s resources in increasing sales force effectiveness and hence productivity. The contribution from exports to total revenues is more than 98% and is further expected to grow over the years. Additionally, Company will continue working with existing alliances to capture untapped growth opportunities.

 

The year ahead holds a new promise as the company plans to strengthen its efforts to launch new global products and provide high quality scientific support - all these with a core focus on patient comes first approach. Key economic indicators, overall confidence in economy and increase in government expenditure on health are expected to have positive impact on healthcare industry. The growing network of their company is providing us strong client base for their future expansion to capture more markets to increase Company’s market share and expand in new geographical areas. Considering the business growth, Company has plan for expansion and renovation of existing manufacturing facilities at Bhiwadi location.

 

 

FIXED ASSETS

 

  • Computer
  • Car
  • Plant and Machinery
  • Furniture and Fixtures
  • Books
  • Dies and Tools
  • Intangible Assets
  • Land and Building

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.70

UK Pound

1

Rs.100.10

Euro

1

Rs.83.81

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION                 

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.